Literature DB >> 21896938

Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats.

Qing Zhu1, Zhengchao Wang, Min Xia, Pin-Lan Li, Benjamin W Van Tassell, Antonio Abbate, Romesh Dhaduk, Ningjun Li.   

Abstract

Although it has been shown that upregulation of hypoxia-inducible factor (HIF)-1α is protective in acute ischemic renal injury, long-term overactivation of HIF-1α is implicated to be injurious in chronic kidney diseases. Angiotensin II (Ang II) is a well-known pathogenic factor producing chronic renal injury and has also been shown to increase HIF-1α. However, the contribution of HIF-1α to Ang II-induced renal injury has not been evidenced. The present study tested the hypothesis that HIF-1α mediates Ang II-induced renal injury in Sprague-Dawley rats. Chronic renal injury was induced by Ang II infusion (200 ng/kg per minute) for 2 weeks in uninephrectomized rats. Transfection of vectors expressing HIF-1α small hairpin RNA into the kidneys knocked down HIF-1α gene expression by 70%, blocked Ang II-induced HIF-1α activation, and significantly attenuated Ang II-induced albuminuria, which was accompanied by inhibition of Ang II-induced vascular endothelial growth factor, a known glomerular permeability factor, in glomeruli. HIF-1α small hairpin RNA also significantly improved the glomerular morphological damage induced by Ang II. Furthermore, HIF-1α small hairpin RNA blocked Ang II-induced upregulation of collagen and α-smooth muscle actin in tubulointerstitial region. There was no difference in creatinine clearance and Ang II-induced increase in blood pressure. HIF-1α small hairpin RNA had no effect on Ang II-induced reduction in renal blood flow and hypoxia in the kidneys. These data suggested that overactivation of HIF-1α-mediated gene regulation in the kidney is a pathogenic pathway mediating Ang II-induced chronic renal injuries, and normalization of overactivated HIF-1α may be used as a treatment strategy for chronic kidney damages associated with excessive Ang II.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896938      PMCID: PMC3174356          DOI: 10.1161/HYPERTENSIONAHA.111.177626

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  69 in total

1.  Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys.

Authors:  Ningjun Li; Fan Yi; Christina M Sundy; Li Chen; Molly L Hilliker; Dustin K Donley; Daniel B Muldoon; Pin-Lan Li
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-01

Review 2.  Cellular and molecular mechanisms of proteinuria in diabetic nephropathy.

Authors:  Gunter Wolf; Fuad N Ziyadeh
Journal:  Nephron Physiol       Date:  2007-06-06

3.  Role of renal medullary heme oxygenase in the regulation of pressure natriuresis and arterial blood pressure.

Authors:  Ningjun Li; Fan Yi; Elisabete A dos Santos; Dustin K Donley; Pin-Lan Li
Journal:  Hypertension       Date:  2006-10-30       Impact factor: 10.190

4.  Salt-sensitive hypertension induced by decoy of transcription factor hypoxia-inducible factor-1alpha in the renal medulla.

Authors:  Ningjun Li; Li Chen; Fan Yi; Min Xia; Pin-Lan Li
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

Review 5.  Hypoxia and the HIF system in kidney disease.

Authors:  Masaomi Nangaku; Kai-Uwe Eckardt
Journal:  J Mol Med (Berl)       Date:  2007-11-20       Impact factor: 4.599

6.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Authors:  Debra F Higgins; Kuniko Kimura; Wanja M Bernhardt; Nikita Shrimanker; Yasuhiro Akai; Bernd Hohenstein; Yoshihiko Saito; Randall S Johnson; Matthias Kretzler; Clemens D Cohen; Kai-Uwe Eckardt; Masayuki Iwano; Volker H Haase
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 7.  Activation of the renin-angiotensin system and chronic hypoxia of the kidney.

Authors:  Masaomi Nangaku; Toshiro Fujita
Journal:  Hypertens Res       Date:  2008-02       Impact factor: 3.872

8.  Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model.

Authors:  Shuichi Ohtomo; Masaomi Nangaku; Yuko Izuhara; Shunya Takizawa; Charles van Ypersele de Strihou; Toshio Miyata
Journal:  Nephrol Dial Transplant       Date:  2007-10-28       Impact factor: 5.992

Review 9.  Monitoring kidney safety in drug development: emerging technologies and their implications.

Authors:  Frank Dieterle; Estelle Marrer; Eiko Suzuki; Olivier Grenet; Andre Cordier; Jacky Vonderscher
Journal:  Curr Opin Drug Discov Devel       Date:  2008-01

10.  Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury.

Authors:  Peter Hill; Deepa Shukla; Maxine G B Tran; Julian Aragones; H Terence Cook; Peter Carmeliet; Patrick H Maxwell
Journal:  J Am Soc Nephrol       Date:  2008-01       Impact factor: 10.121

View more
  43 in total

1.  Inhibition of microRNA-429 in the renal medulla increased salt sensitivity of blood pressure in Sprague Dawley rats.

Authors:  Qing Zhu; Junping Hu; Lei Wang; Weili Wang; Zhengchao Wang; Pin-Lan Li; Krishna M Boini; Ningjun Li
Journal:  J Hypertens       Date:  2017-09       Impact factor: 4.844

2.  Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.

Authors:  Fumiki Yoshihara; Takeshi Tokudome; Ichiro Kishimoto; Kentaro Otani; Atsunori Kuwabara; Takeshi Horio; Yuhei Kawano; Kenji Kangawa
Journal:  Clin Exp Nephrol       Date:  2014-05-21       Impact factor: 2.801

3.  Downregulation of microRNA-429 contributes to angiotensin II-induced profibrotic effect in rat kidney.

Authors:  Zhengchao Wang; Qing Zhu; Weili Wang; Junping Hu; Pin-Lan Li; Fan Yi; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-22

4.  Overexpression of HIF-1α transgene in the renal medulla attenuated salt sensitive hypertension in Dahl S rats.

Authors:  Qing Zhu; Zhengchao Wang; Min Xia; Pin-Lan Li; Fan Zhang; Ningjun Li
Journal:  Biochim Biophys Acta       Date:  2012-02-12

5.  Response: Heroin Use Could Also Be Associated with Ruptured Aortic Aneurysms.

Authors:  Anil Can; Rose Du
Journal:  Transl Stroke Res       Date:  2018-01-09       Impact factor: 6.829

6.  Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension.

Authors:  Yosu Luque; Olivia Lenoir; Philippe Bonnin; Lise Hardy; Anna Chipont; Sandrine Placier; Sophie Vandermeersch; Yi-Chun Xu-Dubois; Blaise Robin; Hélène Lazareth; Michèle Souyri; Léa Guyonnet; Véronique Baudrie; Eric Camerer; Eric Rondeau; Laurent Mesnard; Pierre-Louis Tharaux
Journal:  J Am Soc Nephrol       Date:  2017-09-19       Impact factor: 10.121

7.  Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.

Authors:  Weiru Zhang; Yujin Zhang; Wei Wang; Yingbo Dai; Chen Ning; Renna Luo; Kaiqi Sun; Louise Glover; Almut Grenz; Hong Sun; Lijian Tao; Wenzheng Zhang; Sean P Colgan; Michael R Blackburn; Holger K Eltzschig; Rodney E Kellems; Yang Xia
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

8.  Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury.

Authors:  Caixia Li; Min Xia; Justine M Abais; Xiaocheng Liu; Ningjun Li; Krishna M Boini; Pin-Lan Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-27       Impact factor: 3.000

9.  Silencing of HIF prolyl-hydroxylase 2 gene in the renal medulla attenuates salt-sensitive hypertension in Dahl S rats.

Authors:  Qing Zhu; Junping Hu; Wei-Qing Han; Fan Zhang; Pin-Lan Li; Zhengchao Wang; Ningjun Li
Journal:  Am J Hypertens       Date:  2013-11-04       Impact factor: 2.689

10.  Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3.

Authors:  Bethany Baumann; Tomoko Hayashida; Xiaoyan Liang; H William Schnaper
Journal:  Kidney Int       Date:  2016-08-05       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.